Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Embecta Corp (EMBC)

Embecta Corp (EMBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 602,267
  • Shares Outstanding, K 59,220
  • Annual Sales, $ 1,080 M
  • Annual Income, $ 95,400 K
  • EBIT $ 297 M
  • EBITDA $ 357 M
  • 60-Month Beta 1.11
  • Price/Sales 0.55
  • Price/Cash Flow 2.50
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 53.58% (-0.72%)
  • Historical Volatility 51.84%
  • IV Percentile 14%
  • IV Rank 8.06%
  • IV High 198.18% on 12/18/25
  • IV Low 40.91% on 02/14/25
  • Expected Move (DTE 6) 0.47 (4.60%)
  • Put/Call Vol Ratio 0.11
  • Today's Volume 61
  • Volume Avg (30-Day) 81
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 4,705
  • Open Int (30-Day) 3,999
  • Expected Range 9.70 to 10.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.42
  • Number of Estimates 1
  • High Estimate 0.42
  • Low Estimate 0.42
  • Prior Year 0.70
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.91 +2.62%
on 02/05/26
13.44 -24.36%
on 02/05/26
-2.49 (-19.67%)
since 01/13/26
3-Month
9.91 +2.62%
on 02/05/26
14.81 -31.31%
on 11/21/25
-4.24 (-29.42%)
since 11/13/25
52-Week
9.20 +10.54%
on 06/27/25
16.27 -37.49%
on 02/14/25
-5.98 (-37.03%)
since 02/13/25

Most Recent Stories

More News
embecta names new Chairman of the Board and Lead Independent Director

PARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical...

EMBC : 10.17 (+1.70%)
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results

PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical...

EMBC : 10.17 (+1.70%)
embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...

EMBC : 10.17 (+1.70%)
embecta to Report Fiscal First Quarter Financial Results

PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical...

EMBC : 10.17 (+1.70%)
embecta to Participate at the J.P. Morgan 2026 Healthcare Conference

PARSIPPANY, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday,...

EMBC : 10.17 (+1.70%)
Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance

PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and...

EMBC : 10.17 (+1.70%)
embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...

EMBC : 10.17 (+1.70%)
embecta announces changes to Board of Directors

PARSIPPANY, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical...

EMBC : 10.17 (+1.70%)
embecta Announces Major New Commitment to Direct Relief on World Diabetes Day

PARSIPPANY, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- On World Diabetes Day, embecta Corp. (“embecta”) (Nasdaq: EMBC), the largest manufacturer of insulin injection devices in the world, today announced...

EMBC : 10.17 (+1.70%)
embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results

PARSIPPANY, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical...

EMBC : 10.17 (+1.70%)

Business Summary

Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.

See More

Key Turning Points

3rd Resistance Point 10.80
2nd Resistance Point 10.58
1st Resistance Point 10.38
Last Price 10.17
1st Support Level 9.96
2nd Support Level 9.74
3rd Support Level 9.54

See More

52-Week High 16.27
Fibonacci 61.8% 13.57
Fibonacci 50% 12.74
Fibonacci 38.2% 11.90
Last Price 10.17
52-Week Low 9.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar